On February 23, 2024, China National Medical Products Administration (NMPA) issued the Application Rules for Administrative Penalties in Medical Products Administration, further clarifying how regulatory authorities can impose administrative penalties on enterprises involved in illegal activities. Regarding cosmetics, the provisions on penalty discretion are mainly based on the Cosmetic Supervision and Administration Regulation and its supporting documents, with a particular emphasis on the supervision of children cosmetics and ingredients.